Showing results (231-240 of 265) with videos related to

Sort By:
Pageof 27
Biomedicines|June 2, 2021
Variants in Maternal Effect Genes and Relaxed Imprinting Control in a Special Placental Mesenchymal Dysplasia Case with Mild Trophoblast HyperplasiaTien-Chi Huang, Kung-Chao Chang, Jen-Yun Chang, et al.
Andrologia|September 29, 2021
Efficacy and safety evaluation of low-intensity extracorporeal shock wave therapy on prostatitis-like symptoms: An open-label, single-arm trialChen Jin, Song Zhang, Fan Mo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 3, 2024
Tentacle Microelectrode Arrays Uncover Soft Boundary Neurons in Hippocampal CA1Shiya Lv, Fan Mo, Zhaojie Xu, et al.
Molecular Cancer|March 7, 2015
The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivoAbhijit Parolia, Francesco Crea, Hui Xue, et al.
Cancer Medicine|June 16, 2018
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancerStephen Yiu Chuen Choi, Susan L Ettinger, Dong Lin, et al.
International Journal of Surgery (London, England)|July 17, 2024
Duration of surgical antibiotic prophylaxis and surgical site infection in orthopaedic surgery: a prospective cohort studyZhenbang Yang, Yuchuan Wang, Zhongzheng Wang, et al.
Frontiers in Immunology|October 17, 2022
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapyJiawei Shou, Fan Mo, Shanshan Zhang, et al.
Cell Proliferation|May 18, 2023
An aggregation of human embryonic and trophoblast stem cells reveals the role of trophectoderm on epiblast differentiationXulun Wu, Wentao Zhao, Hao Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2015
Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growthYoshiaki Yamamoto, Yohann Loriot, Eliana Beraldi, et al.
Scientific Reports|February 17, 2017
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapyBernhard Kiss, Alexander W Wyatt, James Douglas, et al.
Pageof 27